135 related articles for article (PubMed ID: 33081659)
1. Synthesis and Evaluation of
Li MH; Chang HC; Feng CF; Yu HW; Shiue CY
Curr Med Imaging; 2020; 16(8):978-990. PubMed ID: 33081659
[TBL] [Abstract][Full Text] [Related]
2. High-Contrast PET Imaging with [
Turkman N; Xu S; Huang CH; Eyermann C; Salino J; Khan P
J Med Chem; 2023 Apr; 66(8):5611-5621. PubMed ID: 37068265
[TBL] [Abstract][Full Text] [Related]
3. The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancer.
Zeglis BM; Pillarsetty N; Divilov V; Blasberg RA; Lewis JS
Nucl Med Biol; 2011 Jul; 38(5):683-96. PubMed ID: 21718944
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Class IIa Histone Deacetylases Expression and In Vivo Epigenetic Imaging in a Transgenic Mouse Model of Alzheimer's Disease.
Chen YA; Lu CH; Ke CC; Chiu SJ; Chang CW; Yang BH; Gelovani JG; Liu RS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445342
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 6-([(18)F]fluoroacetamido)-1-hexanoicanilide for PET imaging of histone deacetylase in the baboon brain.
Reid AE; Hooker J; Shumay E; Logan J; Shea C; Kim SW; Collins S; Xu Y; Volkow N; Fowler JS
Nucl Med Biol; 2009 Apr; 36(3):247-58. PubMed ID: 19324270
[TBL] [Abstract][Full Text] [Related]
6. Radionuclide labeling and evaluation of candidate radioligands for PET imaging of histone deacetylase in the brain.
Seo YJ; Muench L; Reid A; Chen J; Kang Y; Hooker JM; Volkow ND; Fowler JS; Kim SW
Bioorg Med Chem Lett; 2013 Dec; 23(24):6700-5. PubMed ID: 24210501
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Evaluation of 2-[
Kim IS; Kim HS; Kim M; Kwon J; Kim EM; Hwang H; Oh PS; Lim ST; Sohn MH; Kim DH; Jeong HJ
Cancer Biother Radiopharm; 2018 Mar; 33(2):52-59. PubMed ID: 29498544
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Evaluation of an
Tago T; Toyohara J; Ishii K
ACS Chem Neurosci; 2021 Feb; 12(4):746-755. PubMed ID: 33502174
[TBL] [Abstract][Full Text] [Related]
9. In vivo PET imaging of histone deacetylases by 18F-suberoylanilide hydroxamic acid (18F-SAHA).
Hendricks JA; Keliher EJ; Marinelli B; Reiner T; Weissleder R; Mazitschek R
J Med Chem; 2011 Aug; 54(15):5576-82. PubMed ID: 21721525
[TBL] [Abstract][Full Text] [Related]
10. Novel Histone Deacetylase Class IIa Selective Substrate Radiotracers for PET Imaging of Epigenetic Regulation in the Brain.
Bonomi R; Mukhopadhyay U; Shavrin A; Yeh HH; Majhi A; Dewage SW; Najjar A; Lu X; Cisneros GA; Tong WP; Alauddin MM; Liu RS; Mangner TJ; Turkman N; Gelovani JG
PLoS One; 2015; 10(8):e0133512. PubMed ID: 26244761
[TBL] [Abstract][Full Text] [Related]
11. Molecular imaging HDACs class IIa expression-activity and pharmacologic inhibition in intracerebral glioma models in rats using PET/CT/(MRI) with [
Laws MT; Bonomi RE; Kamal S; Gelovani DJ; Llaniguez J; Potukutchi S; Lu X; Mangner T; Gelovani JG
Sci Rep; 2019 Mar; 9(1):3595. PubMed ID: 30837601
[TBL] [Abstract][Full Text] [Related]
12. Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs.
Wang Y; Wallach J; Duane S; Wang Y; Wu J; Wang J; Adejare A; Ma H
Drug Des Devel Ther; 2017; 11():1369-1382. PubMed ID: 28496307
[TBL] [Abstract][Full Text] [Related]
13. Expression of Class I Histone Deacetylases in Ipsilateral and Contralateral Hemispheres after the Focal Photothrombotic Infarction in the Mouse Brain.
Demyanenko S; Neginskaya M; Berezhnaya E
Transl Stroke Res; 2018 Oct; 9(5):471-483. PubMed ID: 29218547
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, biochemical evaluation, radiolabeling and in vivo imaging with high affinity class-IIa histone deacetylase inhibitor for molecular imaging and targeted therapy.
Turkman N; Liu D; Pirola I
Eur J Med Chem; 2022 Jan; 228():114011. PubMed ID: 34875522
[TBL] [Abstract][Full Text] [Related]
15.
Fukumitsu N; Yeh SH; Flores Ii LG; Mukhopadhyay U; Young D; Ogawa K; Jeong HJ; Tong W; Gelovani JG
Contrast Media Mol Imaging; 2018; 2018():3612027. PubMed ID: 29755299
[TBL] [Abstract][Full Text] [Related]
16. Image-guided synthesis reveals potent blood-brain barrier permeable histone deacetylase inhibitors.
Seo YJ; Kang Y; Muench L; Reid A; Caesar S; Jean L; Wagner F; Holson E; Haggarty SJ; Weiss P; King P; Carter P; Volkow ND; Fowler JS; Hooker JM; Kim SW
ACS Chem Neurosci; 2014 Jul; 5(7):588-96. PubMed ID: 24780082
[TBL] [Abstract][Full Text] [Related]
17. In vivo imaging of histone deacetylases (HDACs) in the central nervous system and major peripheral organs.
Wang C; Schroeder FA; Wey HY; Borra R; Wagner FF; Reis S; Kim SW; Holson EB; Haggarty SJ; Hooker JM
J Med Chem; 2014 Oct; 57(19):7999-8009. PubMed ID: 25203558
[TBL] [Abstract][Full Text] [Related]
18. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
[TBL] [Abstract][Full Text] [Related]
19. Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [
Clauß O; Schäker-Hübner L; Wenzel B; Toussaint M; Deuther-Conrad W; Gündel D; Teodoro R; Dukić-Stefanović S; Ludwig FA; Kopka K; Brust P; Hansen FK; Scheunemann M
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337122
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effects of class I histone deacetylases on hippocampal neuroinflammatory regulation in aging mice with postoperative cognitive dysfunction.
Yang CX; Bao F; Zhong J; Zhang L; Deng LB; Sha Q; Jiang H
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10194-10202. PubMed ID: 33090427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]